{"ticker": {"uuid": "29755642-e05f-4073-89cd-1a3af2a51d87", "symbol": "VLA", "name": "Valneva SE", "exchange": "PAR", "country": "FR", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Valneva (NASDAQ: VALN) details access to 2026 Annual General Meeting documents", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOZHlCMktuMGNlem9HTWZidWRMSDRFYW9TSlJuT3g0c3o0S05CSl9pZk1iSnhSU1VvQnJScFpTNTJLSHpwRVRIY1pIQ3BRcEZkQTVUMi1fSU9MNnY5djVDQU5Cbi1HUnNxcFpzandPRmZsYm4wX0UzSFZXdXd6Q0ZHajFhMGJYV3FBSTZWWnhIX1RDQS00VFduVVVMS2NtMUpIYXVuTTl4YmFXdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva (NASDAQ: VALN) registers 31.8M shares, warrants tied to FDA milestone", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOYl9OVV9LZU5ENktJS1lXLVdhS1F2RWlvLXBtTC1CdnA0UGtNUFRSZ18tdmlkUXRSeTM3TGtibTZ3aVJXVHVfM2pQMHFRaXItWnhtY3F0T2w0MkRRRUlCalVpOE9uUy0tM3U2aTUwM3hNR0VFZUlOLTdlbG50dS11ODdMdmNuVEQ3ZW41N2VQS29GTXR4SmdTZVBGWHAtRUR0cC0zdXR2WFlJY21CRURJ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva (NASDAQ: VALN) highlights Lyme vaccine and joins June investor events", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOdzUyckJ3WWYtTlNDcF92cnI3aFlhSEZXNTAtRGh1TzRva2VMbXhQektLaUxrVUlMaVN6RTNnSVNfUl9LZ2lJWnRkZW9jQkJYUHdTc0pvLUhGVnJxWkk1UUZjNGlhTzZHb3I5X2FMblo5YllYal9NUm43NDlJVm5ndTdWMlpfdHVCTGZ4aEUyVU5qWGJVMV8zQXJLQmlxWktKdkxqU1JQTE9wQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "\u20ac5.28: That's What Analysts Think Valneva SE (EPA:VLA) Is Worth After Its Latest Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva SE Stock 12\u2011Month Price Target Cut to $12.98, Implies 116% Upside", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQYU9TWGRrdmlJTExHMV8xRnlRRVhQNWxSZ0hId0F2cHRmSlpaOGJ6bmJ6UDdJdFJnWFhxZ3pTdGJseE9hVUw3OHMzTGQ5UlNLUHpUQThEUDByMWJJQjFidjhBVWVzZXFJUEM2UWVtaUtEeG04bVc4bmZVMXdwa0E4UTB4R0VRVDN0cUdaY2c4TTlrWmYyRkJhSHZLSEhaUEFLelMxWkZlTmpJejVWYzBPcWx5ZVU4RUcyRE0xQTljYUpKMEw5d3J0LW1Qdk4?oc=5", "source_name": "TradingView", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 35, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "French Analyst Ratings: Thales, Vallourec and Valneva in the Spotlight", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPYVpjV1VfY1pGM2c5eVg2LVpVOTF6NEtJLXNvSkU5RUpodFdhVkR2R2djVkRSVlZqOEVZR29TSnB6bnhYQjI3LXFjUmY1ME1XVGR4WVFhNXNMWWs3aFByc1BKTHloVi1ycjBscUF6OFpkVS1JQjNoU2pneDFXRGEtSDVKai1MbTNnMEpIOE52UGxMZ1RxbndoMW1tUnRKcG9FVTNJaVd6eDRyS3V6emJxamphcFVDd2JIQ0JLTGNR?oc=5", "source_name": "marketscreener.com", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva collapses following disappointing news on Lyme disease vaccine", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQQjI2cjdJRGc5V1VPb0dIQm9Cck41UUItX0FJanppYV9wajlwNTkyR0RzUExDakhENjFoSGZBVkk0c0lrR05mSTNsaU9RUnoydUFpMWxTNjROUjN6U01Xb3dsN3dxMzVJSlVQb0YzZ25lOEFqOUx0eHp4QkdGUGloWXZFV0xIaUtuT3dhUk9KcjZvMXl4TTNUVmdWMS1sYjRDT05hRFRvRjVUbkNCelBOWWoxS0lTMmhNN0VqdXNfMzU?oc=5", "source_name": "marketscreener.com", "published_at": "2026-03-23T07:00:00+00:00", "published_display": "23 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva Shares Retreat Amid Technical Pressure", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNTDFjS1E5d1VTRDJjNXJNQm5Vd3BWdEl5dm9mdzZGTmx0ZTlNLVljR2IwdzVabXV3OS1oOEw0QndtYUpCLVp1XzUwejZkQkd1emd6cW9OcENiSTQ4aExNNm9rYmNBMDN1RGRaYzluOHh0N194WVJvYVZOYVpkbExYSXA1SmxmMXAya1pDSHdaaERQV1RaakdRYXNlMVBxNVIyckpUOHNVUkg?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva Stock Forecast 2026\u20132030 | Future Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOUzZnYncxUkx1bDZjMnVTWktyRkF5TU1HT1hDbjZpOUlvdHJaUFJtaU1xNmNCOFkzbkJWTUNvNFAwUDltcXYydXdPM3U5UkwyOXZUeHB5Z096SFF1T2cwcUlhajNQNjZybDBSLXZMM0FEYm9nbDlLZlNJZ2YwOHlhQQ?oc=5", "source_name": "Capital.com", "published_at": "2026-02-13T08:00:00+00:00", "published_display": "13 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is There Now an Opportunity in Valneva After Its 111% Surge in 2025?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-06T07:00:00+00:00", "published_display": "06 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva shares tumble after suspension of US chikungunya vaccine licence", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQc2VCMkRjeWowR3c2anRFaGd2d1lMTWZuTU9LRVdBZEhYVUQ3Ukhab0FxNExUSG14ZHotVVY1R2dkOS0tenpIYUM1OXZ5V3pEbXJpNlhldERTYjBPUks2RGgwMmdiZmMyTHJXWWU0ZFQ1ODRJZm5ia1B6ekxyY1UtU1JmZHlaOE1uaTU1eWQyZ1RkMFVBOHNKTWMtTEp0MUpEbTdLdEJCU3ExRzVVbEhvNUpwRWM3S0x6SmRlRzhZRmdXRmdHVDZ6RzZiYjc4MHRoaGxIX2E5elY?oc=5", "source_name": "Reuters", "published_at": "2025-08-25T07:00:00+00:00", "published_display": "25 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva: presentations planned at conferences", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQcnZjWVpOWldFRk5oZ1BfRkItVFVxVFZyLWpNM08zbTBjU2xnemtLLTBMdGNHUU9fd2tLNU84cG1fTGVOOW9WR1EwakgtRDQwWVd2eC1Cd1JIT1dOZ0tjNWRBXzFlMlJMSHVWNTdBTThzMTlYb3l6bjFuS0l1bVQ1eHBNalJxM2ZocENFdHJEQUpIV0xCZWJoQ2JTMWhlNmVkYUFaTnB6V2VwWnpqS29uZDRmOEt3a1lWN0hZ?oc=5", "source_name": "marketscreener.com", "published_at": "2024-11-12T08:00:00+00:00", "published_display": "12 Nov 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva guides for nearly double product sales by 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOV29BcmhseVAyQWZvNFNQVTVYY0plc1hjYkE3QXgzdWVsMVRrT25Qa3Iyem9PWjk5cVNZcHdncGVudzRuaU5sUnl6N3VVNjVqWEFyT3pIZC1sLUEtS3pINFRNRll6dWFQZjZ1TnBmQ05FNklrbzdWYV9ISTQxNVRrTGxHejd3SmtLQV9zcy1EWGpZZnRDenhkLTBlaEVOVC00T1dQdVNYWUJ5NGpRNldaRUlrWGJ2MUliVk1XdEtqV3YwZXJwbjVwUW9lOS0?oc=5", "source_name": "Reuters", "published_at": "2024-03-20T07:00:00+00:00", "published_display": "20 Mar 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva shares fall as French health body advises against its COVID-19 vaccine", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxPcU1EMm9uTmwwYTlyTEdTOW80bWRNRTJNdUxwQVh3UmQtNFJfQzBwY3VOSHROMzdQMk5hV0xuTEI4aUFKZ2w2TEdUby1DbmJiUWdXcTJIdnExU2lDVUdUR2M2WmsydWFTUXNMSE5vVjF1NFlINjFfRld0WDdzcDNvY1h0ckwzVUF6eG94dGZaRG54TkdXVFZXNVF2QzFIX1FrRDlQQkljVHNHN2pYdXpyOUhIMjlpX2tiNzAyWURnTFpza0EtdXY4VDcxV1ZyV09teEM3LWpVQ2MwOGlGRHA0dg?oc=5", "source_name": "Reuters", "published_at": "2022-12-08T08:00:00+00:00", "published_display": "08 Dec 2022 08:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pfizer to acquire 8.1% share in French firm Valneva", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxOc1dxU2s0eXpULTRFMkxfckFRNWJWTDlRQWZ4SjcxSnRONWN1YXRJTkgxS29SSE5QWE1aQnVtOFh6UFJLWGgtbnNiV2twQ2pXLTV4YXdyaXlDWEU0eUlzMUhBRW9aQnBReFIzVHhrbS1QNTROLVJ3RTVXa3RBU3dxbk9n?oc=5", "source_name": "Pharmaceutical Technology", "published_at": "2022-06-21T07:00:00+00:00", "published_display": "21 Jun 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva shares spike after saying vaccine candidate outperformed AstraZeneca\u2019s", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOZzVjSXJEdEp4bWlTdU1TRmxkOEt5NmZBLTV5UTB1cXlXVGhRdExPM0wtSEJnTlJSOGwwdnpuSjFMLU9fTGM5U3VldXZTX3NCYjRpXzhPazFtWDVyWnFOZEZxT0Rwd1NGMzF0S1duMU1FWnEtR0hzNjhpZEN2N0RxOEU0RWpBVk5PX3ZubURSNzBadVlzcnFpdEZzUldhUmtyOXZwV0ZDd0xrclcxSjVzRU9mUXJlSG9BUVJieG5VMkg?oc=5", "source_name": "MarketWatch", "published_at": "2021-10-18T07:00:00+00:00", "published_display": "18 Oct 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva Plunges After U.K. Scraps Covid Vaccine Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPV1BxS0k5cHpxUFJWbjlTMU1WSmdJRXVSNDRzV28xTlVzMmRTSzZod2RVTHlzNjkxZlNmZ1gydWcyMlctdWk5b1Z4TDFLMlY2OGJxcGFmSUFOVDZCYlNDVHVQWmo2SUpKeTlId29ubWR0UGEwRDQ4aEEzVWpULTV1WUZRejRTVVN1QmVtV1J1bWNMdG9EeVBpOGFLMGxqQ01VNUNWWWxfcU9haXFWRWc?oc=5", "source_name": "Bloomberg", "published_at": "2021-09-13T07:00:00+00:00", "published_display": "13 Sep 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Valneva (NASDAQ: VALN) details access to 2026 Annual General Meeting documents", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOZHlCMktuMGNlem9HTWZidWRMSDRFYW9TSlJuT3g0c3o0S05CSl9pZk1iSnhSU1VvQnJScFpTNTJLSHpwRVRIY1pIQ3BRcEZkQTVUMi1fSU9MNnY5djVDQU5Cbi1HUnNxcFpzandPRmZsYm4wX0UzSFZXdXd6Q0ZHajFhMGJYV3FBSTZWWnhIX1RDQS00VFduVVVMS2NtMUpIYXVuTTl4YmFXdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva (NASDAQ: VALN) registers 31.8M shares, warrants tied to FDA milestone", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOYl9OVV9LZU5ENktJS1lXLVdhS1F2RWlvLXBtTC1CdnA0UGtNUFRSZ18tdmlkUXRSeTM3TGtibTZ3aVJXVHVfM2pQMHFRaXItWnhtY3F0T2w0MkRRRUlCalVpOE9uUy0tM3U2aTUwM3hNR0VFZUlOLTdlbG50dS11ODdMdmNuVEQ3ZW41N2VQS29GTXR4SmdTZVBGWHAtRUR0cC0zdXR2WFlJY21CRURJ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva (NASDAQ: VALN) highlights Lyme vaccine and joins June investor events", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOdzUyckJ3WWYtTlNDcF92cnI3aFlhSEZXNTAtRGh1TzRva2VMbXhQektLaUxrVUlMaVN6RTNnSVNfUl9LZ2lJWnRkZW9jQkJYUHdTc0pvLUhGVnJxWkk1UUZjNGlhTzZHb3I5X2FMblo5YllYal9NUm43NDlJVm5ndTdWMlpfdHVCTGZ4aEUyVU5qWGJVMV8zQXJLQmlxWktKdkxqU1JQTE9wQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "\u20ac5.28: That's What Analysts Think Valneva SE (EPA:VLA) Is Worth After Its Latest Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva SE Stock 12\u2011Month Price Target Cut to $12.98, Implies 116% Upside", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQYU9TWGRrdmlJTExHMV8xRnlRRVhQNWxSZ0hId0F2cHRmSlpaOGJ6bmJ6UDdJdFJnWFhxZ3pTdGJseE9hVUw3OHMzTGQ5UlNLUHpUQThEUDByMWJJQjFidjhBVWVzZXFJUEM2UWVtaUtEeG04bVc4bmZVMXdwa0E4UTB4R0VRVDN0cUdaY2c4TTlrWmYyRkJhSHZLSEhaUEFLelMxWkZlTmpJejVWYzBPcWx5ZVU4RUcyRE0xQTljYUpKMEw5d3J0LW1Qdk4?oc=5", "source_name": "TradingView", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 35, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "French Analyst Ratings: Thales, Vallourec and Valneva in the Spotlight", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPYVpjV1VfY1pGM2c5eVg2LVpVOTF6NEtJLXNvSkU5RUpodFdhVkR2R2djVkRSVlZqOEVZR29TSnB6bnhYQjI3LXFjUmY1ME1XVGR4WVFhNXNMWWs3aFByc1BKTHloVi1ycjBscUF6OFpkVS1JQjNoU2pneDFXRGEtSDVKai1MbTNnMEpIOE52UGxMZ1RxbndoMW1tUnRKcG9FVTNJaVd6eDRyS3V6emJxamphcFVDd2JIQ0JLTGNR?oc=5", "source_name": "marketscreener.com", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva collapses following disappointing news on Lyme disease vaccine", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQQjI2cjdJRGc5V1VPb0dIQm9Cck41UUItX0FJanppYV9wajlwNTkyR0RzUExDakhENjFoSGZBVkk0c0lrR05mSTNsaU9RUnoydUFpMWxTNjROUjN6U01Xb3dsN3dxMzVJSlVQb0YzZ25lOEFqOUx0eHp4QkdGUGloWXZFV0xIaUtuT3dhUk9KcjZvMXl4TTNUVmdWMS1sYjRDT05hRFRvRjVUbkNCelBOWWoxS0lTMmhNN0VqdXNfMzU?oc=5", "source_name": "marketscreener.com", "published_at": "2026-03-23T07:00:00+00:00", "published_display": "23 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva Shares Retreat Amid Technical Pressure", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNTDFjS1E5d1VTRDJjNXJNQm5Vd3BWdEl5dm9mdzZGTmx0ZTlNLVljR2IwdzVabXV3OS1oOEw0QndtYUpCLVp1XzUwejZkQkd1emd6cW9OcENiSTQ4aExNNm9rYmNBMDN1RGRaYzluOHh0N194WVJvYVZOYVpkbExYSXA1SmxmMXAya1pDSHdaaERQV1RaakdRYXNlMVBxNVIyckpUOHNVUkg?oc=5", "source_name": "AD HOC NEWS", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva Stock Forecast 2026\u20132030 | Future Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOUzZnYncxUkx1bDZjMnVTWktyRkF5TU1HT1hDbjZpOUlvdHJaUFJtaU1xNmNCOFkzbkJWTUNvNFAwUDltcXYydXdPM3U5UkwyOXZUeHB5Z096SFF1T2cwcUlhajNQNjZybDBSLXZMM0FEYm9nbDlLZlNJZ2YwOHlhQQ?oc=5", "source_name": "Capital.com", "published_at": "2026-02-13T08:00:00+00:00", "published_display": "13 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is There Now an Opportunity in Valneva After Its 111% Surge in 2025?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-10-06T07:00:00+00:00", "published_display": "06 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva shares tumble after suspension of US chikungunya vaccine licence", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQc2VCMkRjeWowR3c2anRFaGd2d1lMTWZuTU9LRVdBZEhYVUQ3Ukhab0FxNExUSG14ZHotVVY1R2dkOS0tenpIYUM1OXZ5V3pEbXJpNlhldERTYjBPUks2RGgwMmdiZmMyTHJXWWU0ZFQ1ODRJZm5ia1B6ekxyY1UtU1JmZHlaOE1uaTU1eWQyZ1RkMFVBOHNKTWMtTEp0MUpEbTdLdEJCU3ExRzVVbEhvNUpwRWM3S0x6SmRlRzhZRmdXRmdHVDZ6RzZiYjc4MHRoaGxIX2E5elY?oc=5", "source_name": "Reuters", "published_at": "2025-08-25T07:00:00+00:00", "published_display": "25 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva: presentations planned at conferences", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQcnZjWVpOWldFRk5oZ1BfRkItVFVxVFZyLWpNM08zbTBjU2xnemtLLTBMdGNHUU9fd2tLNU84cG1fTGVOOW9WR1EwakgtRDQwWVd2eC1Cd1JIT1dOZ0tjNWRBXzFlMlJMSHVWNTdBTThzMTlYb3l6bjFuS0l1bVQ1eHBNalJxM2ZocENFdHJEQUpIV0xCZWJoQ2JTMWhlNmVkYUFaTnB6V2VwWnpqS29uZDRmOEt3a1lWN0hZ?oc=5", "source_name": "marketscreener.com", "published_at": "2024-11-12T08:00:00+00:00", "published_display": "12 Nov 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva guides for nearly double product sales by 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOV29BcmhseVAyQWZvNFNQVTVYY0plc1hjYkE3QXgzdWVsMVRrT25Qa3Iyem9PWjk5cVNZcHdncGVudzRuaU5sUnl6N3VVNjVqWEFyT3pIZC1sLUEtS3pINFRNRll6dWFQZjZ1TnBmQ05FNklrbzdWYV9ISTQxNVRrTGxHejd3SmtLQV9zcy1EWGpZZnRDenhkLTBlaEVOVC00T1dQdVNYWUJ5NGpRNldaRUlrWGJ2MUliVk1XdEtqV3YwZXJwbjVwUW9lOS0?oc=5", "source_name": "Reuters", "published_at": "2024-03-20T07:00:00+00:00", "published_display": "20 Mar 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva shares fall as French health body advises against its COVID-19 vaccine", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxPcU1EMm9uTmwwYTlyTEdTOW80bWRNRTJNdUxwQVh3UmQtNFJfQzBwY3VOSHROMzdQMk5hV0xuTEI4aUFKZ2w2TEdUby1DbmJiUWdXcTJIdnExU2lDVUdUR2M2WmsydWFTUXNMSE5vVjF1NFlINjFfRld0WDdzcDNvY1h0ckwzVUF6eG94dGZaRG54TkdXVFZXNVF2QzFIX1FrRDlQQkljVHNHN2pYdXpyOUhIMjlpX2tiNzAyWURnTFpza0EtdXY4VDcxV1ZyV09teEM3LWpVQ2MwOGlGRHA0dg?oc=5", "source_name": "Reuters", "published_at": "2022-12-08T08:00:00+00:00", "published_display": "08 Dec 2022 08:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pfizer to acquire 8.1% share in French firm Valneva", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxOc1dxU2s0eXpULTRFMkxfckFRNWJWTDlRQWZ4SjcxSnRONWN1YXRJTkgxS29SSE5QWE1aQnVtOFh6UFJLWGgtbnNiV2twQ2pXLTV4YXdyaXlDWEU0eUlzMUhBRW9aQnBReFIzVHhrbS1QNTROLVJ3RTVXa3RBU3dxbk9n?oc=5", "source_name": "Pharmaceutical Technology", "published_at": "2022-06-21T07:00:00+00:00", "published_display": "21 Jun 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva shares spike after saying vaccine candidate outperformed AstraZeneca\u2019s", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOZzVjSXJEdEp4bWlTdU1TRmxkOEt5NmZBLTV5UTB1cXlXVGhRdExPM0wtSEJnTlJSOGwwdnpuSjFMLU9fTGM5U3VldXZTX3NCYjRpXzhPazFtWDVyWnFOZEZxT0Rwd1NGMzF0S1duMU1FWnEtR0hzNjhpZEN2N0RxOEU0RWpBVk5PX3ZubURSNzBadVlzcnFpdEZzUldhUmtyOXZwV0ZDd0xrclcxSjVzRU9mUXJlSG9BUVJieG5VMkg?oc=5", "source_name": "MarketWatch", "published_at": "2021-10-18T07:00:00+00:00", "published_display": "18 Oct 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valneva Plunges After U.K. Scraps Covid Vaccine Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPV1BxS0k5cHpxUFJWbjlTMU1WSmdJRXVSNDRzV28xTlVzMmRTSzZod2RVTHlzNjkxZlNmZ1gydWcyMlctdWk5b1Z4TDFLMlY2OGJxcGFmSUFOVDZCYlNDVHVQWmo2SUpKeTlId29ubWR0UGEwRDQ4aEEzVWpULTV1WUZRejRTVVN1QmVtV1J1bWNMdG9EeVBpOGFLMGxqQ01VNUNWWWxfcU9haXFWRWc?oc=5", "source_name": "Bloomberg", "published_at": "2021-09-13T07:00:00+00:00", "published_display": "13 Sep 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 82, "total_relevant": 17, "sentiment_summary": {"positive": 1, "negative": 3, "neutral": 13, "score": 47, "total": 17, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 8.0, "count": 12}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.9, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 2.31, "latest_week": "2026-06-19", "one_week_move": 0.8, "four_week_move": -6.9, "twelve_week_move": -16.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.12524, "market_dynamics_buy_signal": false, "relative_strength": -38.496822, "fair_value_gap": -38.2, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 42.9237, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.8% over one week, -6.9% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 53, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 3}, {"label": "marketscreener.com", "count": 3}, {"label": "Reuters", "count": 3}, {"label": "simplywall.st", "count": 2}, {"label": "TradingView", "count": 1}, {"label": "AD HOC NEWS", "count": 1}, {"label": "Capital.com", "count": 1}, {"label": "Pharmaceutical Technology", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 17}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 12}, {"label": "Analyst action", "count": 2}, {"label": "Earnings", "count": 1}, {"label": "Guidance", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "47/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "17", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "5", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.8% over one week, -6.9% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Valneva (NASDAQ: VALN) details access to 2026 Annual General Meeting documents"}], "updated_at": "2026-06-23T00:07:35.156230+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}